How to Set Up an International Patient Department (Medical Tourism) in India (2026)
November 18, 2026Green Hospital Design & Certification in India: IGBC vs GRIHA (2026)
November 18, 2026Hospital Marketing & Branding in India: NMC, ASCI & Legal Limits (2026)
Hospital marketing in India looks, on the surface, like any other consumer marketing problem — build a brand, run campaigns, generate leads. It isn't. Three separate regulatory frameworks constrain what a hospital can say about itself, its doctors and its outcomes, and the rules tightened meaningfully in October 2026 when the National Medical Commission extended advertising restrictions that previously applied only to individual doctors onto hospitals and corporate medical institutions directly.
This guide sets out what's actually restricted and what remains open for a new hospital building its brand. If you're earlier in planning and haven't settled your positioning yet, our hospital licensing guide and NABH accreditation guide are worth finishing first, since accreditation status itself is one of the few claims you can make with confidence.
In this guide ▾
- The NMC's October 2026 Guidelines on Ethical Advertising and Public Communication extend advertising restrictions, previously applicable mainly to individual Registered Medical Practitioners, directly to hospitals and corporate medical institutions.
- Three regulators govern hospital advertising in practice: the NMC (medical ethics), the Advertising Standards Council of India/ASCI (self-regulatory ad standards, with specific Healthcare Guidelines), and the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 (cure-claim restrictions for specified diseases).
- Self-promotion, misleading reviews and unsubstantiated testimonials are explicitly restricted under the new NMC guidelines.
- The NMC guidelines specifically restrict the use of AI for commercial promotion in healthcare advertising — a new and notable provision as of the 2026 guidelines.
- Superlative claims and comparative advertising (e.g. 'best', 'No. 1', outcome comparisons against competitors) are a recurring enforcement flashpoint under ASCI's healthcare guidelines, which require documentary evidence for efficacy claims.
Step 1: Know which regulator governs what
| Regulator | What it governs |
|---|---|
| National Medical Commission (NMC) | Medical ethics and professional conduct; its October 2026 Guidelines on Ethical Advertising and Public Communication now explicitly cover hospitals and corporate medical institutions, not just individual doctors |
| Advertising Standards Council of India (ASCI) | Self-regulatory advertising standards body; its Healthcare Guidelines (2023, updated 2024) address superlative claims, comparative advertising and efficacy representations specifically |
| Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 | Restricts advertisements claiming to cure or treat specified diseases and conditions, regardless of the medium used |
The practical effect for a new hospital: your marketing agency’s usual playbook of superlative claims, before/after outcome comparisons and unverified patient testimonials is now a direct compliance exposure, not just a brand-tone choice.
Step 2: What’s specifically restricted
- Self-promotion and misleading claims by hospitals and institutions, explicitly named in the NMC’s October 2026 guidelines;
- misleading reviews and testimonials — patient testimonials used as advertising, without substantiation, are a specific target of the new guidelines;
- AI used for commercial promotion — the NMC guidelines place specific restrictions here, a new and notable addition reflecting growing use of AI-generated content in healthcare marketing;
- superlative and comparative claims (e.g. ‘India’s best’, outcome or success-rate comparisons against named or implied competitors) without documentary evidence, under ASCI’s Healthcare Guidelines;
- cure claims for specified diseases — advertisements claiming to cure or materially treat certain conditions are restricted under the Drugs and Magic Remedies Act regardless of platform.
Enforcement responsibility is shared: ASCI issues complaint-based rulings through its self-regulatory process, while the NMC’s guidelines carry professional-conduct consequences for registered practitioners and, now, institutional consequences for hospitals as entities.
If a campaign states a success rate, a patient volume, or any comparative claim, keep the documented clinical or statistical basis for it on file before the ad runs, not after a complaint arrives. Both ASCI and the NMC frameworks put the evidentiary burden on the advertiser.
Step 3: What’s still open to build a brand around
- Accreditation status (NABH, JCI) and specific, verifiable certifications — these are factual, documented claims, not superlative ones;
- facility, equipment and infrastructure descriptions — describing what you have (a hybrid OT, a specific imaging system) is informational, not a clinical outcome claim;
- general health education content — published patient-education material, when not tied to a promotional claim about your specific superiority, generally sits outside these restrictions;
- institutional brand presence — name, visual identity, facility photography and general positioning remain open ground, provided none of it strays into the restricted categories above.
Most hospitals still have significant room to build a strong brand through accreditation credibility, patient experience design (see our patient flow and hospital design guide) and transparent, factual communication, without relying on the superlative claims that now carry the most regulatory risk.
Step 4: Practical steps for your marketing function
| Action | Why |
|---|---|
| Brief your marketing/ad agency on the current NMC and ASCI frameworks explicitly | Most agencies are not healthcare-specialist and may default to standard consumer-marketing claims |
| Build a documentation file for any outcome, success-rate or comparative claim before publishing | Shifts your position from reactive to defensible if a complaint is raised |
| Review AI-generated marketing content against the NMC’s specific AI-promotion restrictions | This is a new and actively evolving area of enforcement as of the 2026 guidelines |
| Route doctor-specific promotional content through the same compliance review as institutional content | The 2023 RMP conduct regulations and the 2026 hospital guidelines are designed to apply consistently across both |
Launch checklist
- Brief your marketing team or agency on NMC’s October 2026 ethical advertising guidelines and ASCI’s healthcare rules.
- Avoid superlative claims (‘best’, ‘No. 1’) and unsubstantiated comparative advertising.
- Keep documented evidence on file for any outcome, success-rate or efficacy claim before it’s published.
- Review any AI-generated marketing content specifically against the new AI-promotion restrictions.
- Avoid using patient testimonials as advertising without clear substantiation and consent.
- Build your brand around verifiable facts: accreditation status, infrastructure, and transparent patient communication.
- Keep doctor-specific and institutional marketing content under the same compliance review process.
Frequently asked questions
Can a hospital say it has the 'best' doctors or outcomes in its city?
This kind of superlative claim is a recurring flashpoint under ASCI's Healthcare Guidelines, which require documentary evidence for efficacy and comparative claims. Without substantiated evidence on file, such claims carry meaningful compliance risk.
Are patient testimonials banned entirely?
The NMC's October 2026 guidelines specifically restrict misleading reviews and testimonials used as advertising. Genuine, substantiated patient experiences shared with proper consent sit on firmer ground than unverified promotional testimonials, but this is an area to review carefully with current guidance.
Do these rules apply to social media and digital marketing, or only traditional advertising?
The frameworks are generally medium-agnostic: the Drugs and Magic Remedies Act's cure-claim restrictions, ASCI's Healthcare Guidelines and the NMC's 2026 guidelines all apply regardless of whether the content runs in print, on a website, or on social media.
What changed specifically in October 2026?
The NMC issued new Guidelines on Ethical Advertising and Public Communication, extending advertising-ethics obligations that previously applied mainly to individual Registered Medical Practitioners directly onto hospitals and corporate medical institutions, following a Supreme Court writ petition on the issue.
Can a hospital advertise using AI-generated content?
The NMC's 2026 guidelines place specific restrictions on using AI for commercial promotion in healthcare advertising. Review any AI-generated marketing content against these restrictions before publishing, as this is an actively evolving area of the guidelines.
Build a compliant hospital brand with Hospertz
Marketing compliance review, positioning strategy and accreditation-led branding.
Keep reading
Advertising regulations referenced here (NMC guidelines, ASCI Healthcare Guidelines, the Drugs and Magic Remedies Act) are subject to ongoing legal and regulatory development, including possible further Supreme Court directions. Confirm current requirements with legal counsel before finalising any marketing campaign. This article is general information, not legal advice.
Get a compliance check against current NMC and ASCI guidelines.
Free consultationWhatsApp us


